Time_PatienceMar 27TNXP Could still go down for retesting $17. still enough time till FDA gives green light.
BodinkMar 21TNXP DOW JONESI NEWSWIRESTonix PharmaceuticalsPrice Target Maintained With a $70.00/Share by Noble Capital Markets12:27 • Mar 20TONIX TNXP